Chieh-hsin F. Lin

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 107 publications

Superoxide dismutase and glutathione interact to determine cognitive outcome among people with subjective cognitive decline (SCD): a prospective study.

Superoxide dismutase and glutathione interact to determine cognitive outcome among people with subjective cognitive decline (SCD): a prospective study.

Journal: European archives of psychiatry and clinical neuroscience

Published: May 11, 2026

Both the PANSS cognitive component and MATRICS consensus cognitive domains are linked to functional outcome in patients with schizophrenia: A cross-sectional study.

Both the PANSS cognitive component and MATRICS consensus cognitive domains are linked to functional outcome in patients with schizophrenia: A cross-sectional study.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: January 27, 2026

Sodium benzoate, a D-amino acids oxidase inhibitor, for the treatment of mild cognitive impairment: Pooled data from three randomized, double-blind, placebo-controlled trials.

Sodium benzoate, a D-amino acids oxidase inhibitor, for the treatment of mild cognitive impairment: Pooled data from three randomized, double-blind, placebo-controlled trials.

Journal: Psychiatry and clinical neurosciences

Published: December 26, 2025

Gender-specific effects of sodium benzoate on cognitive improvement in individuals with dementia: a meta-analysis of randomized controlled trials.

Gender-specific effects of sodium benzoate on cognitive improvement in individuals with dementia: a meta-analysis of randomized controlled trials.

Journal: European archives of psychiatry and clinical neuroscience

Published: October 17, 2025

Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial.

Sodium benzoate treatment linked to increased glutathione levels and improved positive and negative symptoms, global function, and quality of life in patients with clozapine-resistant schizophrenia: secondary analysis of a randomized clinical trial.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: August 29, 2025

Role of emotional intelligence in schizophrenia: ability-based vs. self-reported assessment.

Role of emotional intelligence in schizophrenia: ability-based vs. self-reported assessment.

Journal: European archives of psychiatry and clinical neuroscience

Published: July 21, 2025

Sodium benzoate, a D-amino acid oxidase inhibitor, improved short-term memory in patients with mild cognitive impairment in a randomized, double-blind, placebo-controlled clinical trial.

Sodium benzoate, a D-amino acid oxidase inhibitor, improved short-term memory in patients with mild cognitive impairment in a randomized, double-blind, placebo-controlled clinical trial.

Journal: Psychiatry and clinical neurosciences

Published: March 03, 2025

Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trial.

Sodium benzoate treatment decreased amyloid beta peptides and improved cognitive function among patients with Alzheimer's disease: secondary analysis of a randomized clinical trial.

Journal: Translational psychiatry

Published: February 01, 2025

The double-edged roles of testosterone in cognitive function and behavioral/psychological symptoms of patients with dementia.

The double-edged roles of testosterone in cognitive function and behavioral/psychological symptoms of patients with dementia.

Journal: Psychiatry research

Published: January 06, 2025

Symptomatic and cognitive effects of D-amino acid oxidase inhibitors in patients with schizophrenia: a meta-analysis of double-blind randomized controlled trials.

Symptomatic and cognitive effects of D-amino acid oxidase inhibitors in patients with schizophrenia: a meta-analysis of double-blind randomized controlled trials.

Journal: Schizophrenia (Heidelberg, Germany)

Published: December 22, 2024

Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate.

Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate.

Journal: Psychiatry and clinical neurosciences

Published: December 17, 2024

Interpretable machine learning to evaluate relationships between DAO/DAOA (pLG72) protein data and features in clinical assessments, functional outcome, and cognitive function in schizophrenia patients.

Interpretable machine learning to evaluate relationships between DAO/DAOA (pLG72) protein data and features in clinical assessments, functional outcome, and cognitive function in schizophrenia patients.

Journal: Schizophrenia (Heidelberg, Germany)

Published: September 25, 2024

Showing 1-12 of 107

Last Updated: 09/26/2026